Idiopathic Juvenile Osteoporosis

Download PDF

Recent Publications on Idiopathic Juvenile Osteoporosis:
Idiopathic juvenile osteoporosis--an analysis of the muscle-bone relationship. INTRODUCTION: Idiopathic Juvenile Osteoporosis (IJO), a disease of unknown...	11th January, 2007	Department of Biochemistry and Experimental Medicine, The Children's	Osteoporos Int. 2006;17(11):1681-90. Epub 2006 Sep 2. DOI Direct Link
Bisphosphonate treatment of pediatric bone disease. The science of measuring bone mineral density has developed rapidly and,...	29th March, 2006	Schneider Children's Hospital and New York University School of Medicine,	Pediatr Endocrinol Rev. 2005 Dec;3(2):87-96.
How to manage osteoporosis in children. Osteoporosis is increasingly being seen in young people. The primitive...	17th February, 2006	Bone Metabolism Unit, Istituto Auxologico Italiano, IRCCS, Via L. Ariosto,	Best Pract Res Clin Rheumatol. 2005 Dec;19(6):991-1005. DOI Direct Link
Three children with lower limb fractures and a mineralization defect: a novel bone fragility disorder? In this report, we describe three unrelated children with an apparently...	7th September, 2005	Genetics Unit, Shriners Hospital for Children, Montreal, Quebec, Canada.	Bone. 2004 Nov;35(5):1023-8. DOI Direct Link
Effective parenteral clodronate treatment of a child with severe juvenile idiopathic osteoporosis. We report on an 8 years and 3 months old boy with severe idiopathic...	13th April, 2005	Children's Hospital, Klinikum Kassel, Kassel, Germany.	Eur J Pediatr. 2005 Jan;164(1):22-7. Epub 2004 Oct 23. DOI Direct Link
→View more research publications.

Idiopathic Juvenile Osteoporosis Clinical Trials:
Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis	Osteoporosis Intervention: Drug: alendronate

Idiopathic Juvenile Osteoporosis Patents:
US Patent No.	Title
7192938	Method of treatment using bisphosphonic acid
7179629	Regulation of human serine/threonine kinase
7087225	Methods and compositions for treating metabolic bone diseases relating to human endokine alpha
5616576	Controlling bone resorption with pyrroloquinoline quinone (PQQ) and related compounds

BioPortfolio Ltd. offers e-mail and postal lists for Idiopathic Juvenile Osteoporosis scientists - we have details of around 7 individuals working on Idiopathic Juvenile Osteoporosis .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.